Shares of Koninklijke Philips (NYSE:PHG – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five research firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company.
Several research analysts recently commented on the stock. StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday.
View Our Latest Report on Koninklijke Philips
Institutional Investors Weigh In On Koninklijke Philips
Koninklijke Philips Trading Down 0.4 %
NYSE PHG opened at $26.23 on Tuesday. The firm has a market cap of $24.65 billion, a PE ratio of -62.44, a price-to-earnings-growth ratio of 1.04 and a beta of 0.74. Koninklijke Philips has a 1-year low of $18.79 and a 1-year high of $32.91. The stock has a 50-day moving average of $30.86 and a 200-day moving average of $27.85. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60.
Koninklijke Philips (NYSE:PHG – Get Free Report) last announced its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. The business had revenue of $4.80 billion for the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. As a group, sell-side analysts forecast that Koninklijke Philips will post 1.59 EPS for the current year.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- ETF Screener: Uses and Step-by-Step Guide
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.